[144] United States Cellular Corporation 5.500% Senior Notes due 2070 SEC Filing
Form 144 notice: The filing reports a proposed sale of 73,934 shares of the issuer's common stock through the broker listed as Vanguard Marketing Corporation, with an aggregate market value of 5618984.00. The proposed sale is slated for 08/12/2025 on the NYSE and the filing indicates 53,000,000 shares outstanding.
The securities were acquired as stock awards from the company on 04/02/2021. The filer reports "Nothing to Report" for securities sold in the past three months and includes the standard representation that they do not possess undisclosed material adverse information about the issuer.
Avviso del Modulo 144: La comunicazione segnala la proposta vendita di 73,934 azioni del capitale ordinario dell'emittente tramite il broker indicato come Vanguard Marketing Corporation, con un valore di mercato aggregato di 5618984.00. La vendita è prevista per il 08/12/2025 sul NYSE e la comunicazione indica 53,000,000 azioni in circolazione.
Le securities sono state acquisite come assegnazioni di azioni dalla società il 04/02/2021. Il dichiarante segnala "Nothing to Report" per le securities vendute negli ultimi tre mesi e include la rappresentazione standard di non possedere informazioni materiali sfavorevoli non divulgate sull'emittente.
Aviso del Formulario 144: La presentación informa una propuesta de venta de 73,934 acciones del capital ordinario del emisor a través del corredor indicado como Vanguard Marketing Corporation, con un valor de mercado agregado de 5618984.00. La venta propuesta está prevista para el 08/12/2025 en la NYSE y la presentación indica 53,000,000 acciones en circulación.
Los valores fueron adquiridos como adjudicaciones de acciones de la compañía el 04/02/2021. El declarante informa "Nothing to Report" respecto a valores vendidos en los últimos tres meses e incluye la declaración estándar de no poseer información adversa material no divulgada sobre el emisor.
Form 144 통지: 제출서류는 브로커로 명시된 Vanguard Marketing Corporation을 통해 발행회사의 보통주 73,934주를 매도할 예정이라고 보고하며, 총 시가 5618984.00로 명시되어 있습니다. 제안된 매도는 08/12/2025에 NYSE에서 예정되어 있고, 제출서류는 53,000,000주의 발행주식을 기재하고 있습니다.
해당 증권은 주식 보상으로 회사로부터 04/02/2021에 취득되었습니다. 신고인은 지난 3개월 동안 매각된 증권에 대해 "Nothing to Report"라고 보고하며, 발행인에 대해 공개되지 않은 중대한 불리한 정보가 없음을 표준적으로 진술하고 있습니다.
Avis Formulaire 144 : Le dépôt signale une proposition de vente de 73,934 actions ordinaires de l'émetteur par l'intermédiaire du courtier indiqué comme Vanguard Marketing Corporation, pour une valeur de marché agrégée de 5618984.00. La vente proposée est prévue pour le 08/12/2025 sur le NYSE et le dépôt indique 53,000,000 actions en circulation.
Les titres ont été acquis en tant que attributions d'actions de la société le 04/02/2021. Le déclarant indique "Nothing to Report" pour les titres vendus au cours des trois derniers mois et inclut la déclaration standard selon laquelle il ne possède pas d'informations défavorables importantes non divulguées concernant l'émetteur.
Formular 144-Mitteilung: Die Meldung berichtet über einen geplanten Verkauf von 73,934 Aktien der Stammaktien des Emittenten über den als Broker genannten Vanguard Marketing Corporation, mit einem aggregierten Marktwert von 5618984.00. Der geplante Verkauf ist für den 08/12/2025 an der NYSE vorgesehen, und die Meldung gibt 53,000,000 ausstehende Aktien an.
Die Wertpapiere wurden am 04/02/2021 als Aktienzuteilungen vom Unternehmen erworben. Der Melder gibt für in den letzten drei Monaten verkaufte Wertpapiere "Nothing to Report" an und enthält die übliche Erklärung, keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten zu besitzen.
- Proposed sale disclosed transparently with broker, quantity, aggregate market value, sale date, and exchange specified
- Securities were acquired as stock awards and acquisition date (04/02/2021) is provided
- Filer reports no securities sold in the past three months ("Nothing to Report")
- Filer contact and CIK/CCC fields are not populated in the provided text
- Filing contains limited context about the identity of the selling person and their relationship beyond the note 'Relationship to Issuer' (no detailed disclosure provided)
Insights
TL;DR: Routine Rule 144 notice for an insider sale of company-granted shares; amount appears modest relative to total outstanding shares.
The filing documents a proposed disposition of 73,934 common shares acquired as stock awards on 04/02/2021, to be executed via Vanguard Marketing Corporation on the NYSE on 08/12/2025, with an aggregate market value reported as 5618984.00. The filer indicates no other sales in the prior three months. This is a standard disclosure under Rule 144; it notifies the market of a planned sale but does not itself change company fundamentals.
TL;DR: Compliance-focused filing showing disclosure of a share sale by a person who received stock awards; procedural, not a governance event.
The form confirms the seller acquired the securities via company stock awards and has attested to the absence of undisclosed material adverse information. The document is primarily procedural, fulfilling regulatory requirements for the public disclosure of an insider sale under Rule 144. It does not report related-party transactions, departures, or other governance actions.
Avviso del Modulo 144: La comunicazione segnala la proposta vendita di 73,934 azioni del capitale ordinario dell'emittente tramite il broker indicato come Vanguard Marketing Corporation, con un valore di mercato aggregato di 5618984.00. La vendita è prevista per il 08/12/2025 sul NYSE e la comunicazione indica 53,000,000 azioni in circolazione.
Le securities sono state acquisite come assegnazioni di azioni dalla società il 04/02/2021. Il dichiarante segnala "Nothing to Report" per le securities vendute negli ultimi tre mesi e include la rappresentazione standard di non possedere informazioni materiali sfavorevoli non divulgate sull'emittente.
Aviso del Formulario 144: La presentación informa una propuesta de venta de 73,934 acciones del capital ordinario del emisor a través del corredor indicado como Vanguard Marketing Corporation, con un valor de mercado agregado de 5618984.00. La venta propuesta está prevista para el 08/12/2025 en la NYSE y la presentación indica 53,000,000 acciones en circulación.
Los valores fueron adquiridos como adjudicaciones de acciones de la compañía el 04/02/2021. El declarante informa "Nothing to Report" respecto a valores vendidos en los últimos tres meses e incluye la declaración estándar de no poseer información adversa material no divulgada sobre el emisor.
Form 144 통지: 제출서류는 브로커로 명시된 Vanguard Marketing Corporation을 통해 발행회사의 보통주 73,934주를 매도할 예정이라고 보고하며, 총 시가 5618984.00로 명시되어 있습니다. 제안된 매도는 08/12/2025에 NYSE에서 예정되어 있고, 제출서류는 53,000,000주의 발행주식을 기재하고 있습니다.
해당 증권은 주식 보상으로 회사로부터 04/02/2021에 취득되었습니다. 신고인은 지난 3개월 동안 매각된 증권에 대해 "Nothing to Report"라고 보고하며, 발행인에 대해 공개되지 않은 중대한 불리한 정보가 없음을 표준적으로 진술하고 있습니다.
Avis Formulaire 144 : Le dépôt signale une proposition de vente de 73,934 actions ordinaires de l'émetteur par l'intermédiaire du courtier indiqué comme Vanguard Marketing Corporation, pour une valeur de marché agrégée de 5618984.00. La vente proposée est prévue pour le 08/12/2025 sur le NYSE et le dépôt indique 53,000,000 actions en circulation.
Les titres ont été acquis en tant que attributions d'actions de la société le 04/02/2021. Le déclarant indique "Nothing to Report" pour les titres vendus au cours des trois derniers mois et inclut la déclaration standard selon laquelle il ne possède pas d'informations défavorables importantes non divulguées concernant l'émetteur.
Formular 144-Mitteilung: Die Meldung berichtet über einen geplanten Verkauf von 73,934 Aktien der Stammaktien des Emittenten über den als Broker genannten Vanguard Marketing Corporation, mit einem aggregierten Marktwert von 5618984.00. Der geplante Verkauf ist für den 08/12/2025 an der NYSE vorgesehen, und die Meldung gibt 53,000,000 ausstehende Aktien an.
Die Wertpapiere wurden am 04/02/2021 als Aktienzuteilungen vom Unternehmen erworben. Der Melder gibt für in den letzten drei Monaten verkaufte Wertpapiere "Nothing to Report" an und enthält die übliche Erklärung, keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten zu besitzen.
FAQ
What does the UZE Form 144 report?
How were the shares acquired according to the filing?
Does the filing report other sales in the past three months for UZE?
Which broker is handling the sale listed on the Form 144?
What representation does the seller make in the Remarks section?
